← Leaderboards
Reza Nezafat
Beth Israel Deaconess Medical Center
$25,541,717
Attributed
$28,913,712
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,913,712 · 11
By mechanism
R01$27,959,462 · 9
R21$954,250 · 2
Top collaborators
- Martin S Maron5 shared
- Elad Anter2 shared
- Seshadri Balaji1 shared
- Lars Grosse-Wortmann1 shared
- Mark E. Josephson1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Francesca N Delling$5,534,111
- Laura G Burke$2,265,337
- Prashant Rao$190,491
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacImageMortalityGadoliniumCicatrixCardiovascular SystemFibrosisMyocardialCostHeartTissuesMyocardial TissueBiological MarkersMagnetic Resonance ImagingDiffusePhenotypeMorbidity - Disease RateImaging BiomarkerFunctional DisorderUnited StatesHeart FailureBreathingArrhythmiaBase
Grant awards (40)
iPRISM (Imaging-enhanced Prediction of RIsk for Sudden cardiac death in hcM)$1,289,113
R01 · FY2025 · HL
Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMR$777,258
R01 · FY2025 · HL · contact PI
Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction$726,778
R01 · FY2025 · HL · contact PI
Cardiovascular MRI Characterization of the Arrhythmogenic Heart in Nonischemic Cardiomyopathy$744,356
R01 · FY2024 · HL · contact PI
Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction$715,193
R01 · FY2024 · HL · contact PI
Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM$675,466
R01 · FY2024 · HL · contact PI
Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis$860,262
R01 · FY2023 · HL · contact PI
Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM$766,468
R01 · FY2023 · HL · contact PI
Cardiovascular MRI Characterization of the Arrhythmogenic Heart in Nonischemic Cardiomyopathy$764,497
R01 · FY2023 · HL · contact PI
Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction$735,696
R01 · FY2023 · HL · contact PI
Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis$862,762
R01 · FY2022 · HL · contact PI
Cardiovascular MRI Characterization of the Arrhythmogenic Heart in Nonischemic Cardiomyopathy$771,809
R01 · FY2022 · HL · contact PI
Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM$750,428
R01 · FY2022 · HL · contact PI
Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction$742,389
R01 · FY2022 · HL · contact PI
Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis$864,762
R01 · FY2021 · HL · contact PI
Cardiovascular MRI Characterization of the Arrhythmogenic Heart in Nonischemic Cardiomyopathy$810,587
R01 · FY2021 · HL · contact PI
Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction$783,751
R01 · FY2021 · HL · contact PI
Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM$782,727
R01 · FY2021 · HL · contact PI
Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis$946,194
R01 · FY2020 · HL · contact PI
Myocardial Tissue Characterization with MR Relaxometry in Heart Failure$853,155
R01 · FY2020 · HL · contact PI
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer$1
R01 · FY2020 · HL · contact PI
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer$861,924
R01 · FY2019 · HL · contact PI
Myocardial Tissue Characterization with MR Relaxometry in Heart Failure$752,436
R01 · FY2019 · HL · contact PI
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer$860,001
R01 · FY2018 · HL · contact PI
Cardiac MR Characterization of Arrhythmogenic Scar in Patients with Myocardial Infarction$848,603
R01 · FY2018 · HL · contact PI
Myocardial Tissue Characterization with MR Relaxometry in Heart Failure$772,801
R01 · FY2018 · HL · contact PI
Cardiac MR Characterization of Arrhythmogenic Scar in Patients with Myocardial Infarction$890,642
R01 · FY2017 · HL · contact PI
Myocardial Tissue Characterization with MR Relaxometry in Heart Failure$867,571
R01 · FY2017 · HL · contact PI
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer$851,351
R01 · FY2017 · HL · contact PI
Quantitative Cardiac MRI for Detection of Subclinical Cardiotoxicity in Breast Cancer$259,500
R21 · FY2017 · HL · contact PI
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer$878,251
R01 · FY2016 · HL · contact PI
Cardiac MR Characterization of Arrhythmogenic Scar in Patients with Myocardial Infarction$821,616
R01 · FY2016 · HL · contact PI
MRI Characterization of Arrhythmogenic Scar in Ventricular Tachycardia$217,500
R21 · FY2016 · HL · contact PI
Quantitative Cardiac MRI for Detection of Subclinical Cardiotoxicity in Breast Cancer$216,250
R21 · FY2016 · HL · contact PI
Cardiac MR Characterization of Arrhythmogenic Scar in Patients with Myocardial Infarction$794,326
R01 · FY2015 · HL · contact PI
MRI Characterization of Arrhythmogenic Scar in Ventricular Tachycardia$261,000
R21 · FY2015 · HL · contact PI
An XFM Interventional Guidance System for Cardiac Resynchronization Therapy$664,468
R01 · FY2012 · EB · contact PI
An XFM Interventional Guidance System for Cardiac Resynchronization Therapy$628,777
R01 · FY2011 · EB · contact PI
An XFM Interventional Guidance System for Cardiac Resynchronization Therapy$617,127
R01 · FY2010 · EB · contact PI
An XFM Interventional Guidance System for Cardiac Resynchronization Therapy$625,916
R01 · FY2009 · EB · contact PI